Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Mar;6(1):121-9.
doi: 10.1007/s11481-010-9217-8. Epub 2010 Apr 23.

Activation of Egr-1 expression in astrocytes by HIV-1 Tat: new insights into astrocyte-mediated Tat neurotoxicity

Affiliations

Activation of Egr-1 expression in astrocytes by HIV-1 Tat: new insights into astrocyte-mediated Tat neurotoxicity

Yan Fan et al. J Neuroimmune Pharmacol. 2011 Mar.

Abstract

Human immunodeficiency virus type 1 (HIV-1) Tat plays an important role in HIV-associated neuropathogenesis; the underlying mechanisms are still evolving. We have recently shown that HIV-1 Tat induces expression of glial fibrillary acidic protein (GFAP), a characteristic of HIV-1 infection of the central nervous system. We have also shown that the Tat-induced GFAP expression in astrocytes is regulated by p300 and that deletion of the early growth response 1 (Egr-1) cis-transacting element within the p300 promoter abolishes Tat-induced GFAP expression. In this study, we further examined the relationship between Tat and Egr-1 in astrocytes. We found increased Egr-1 protein expression in Tat-expressing human astrocytoma cells and mouse primary astrocytes. Using the Egr-1 promoter-driven firefly luciferase reporter gene assay and the site-directed mutagenesis, we demonstrated that Tat increased Egr-1 expression by transactivating the Egr-1 promoter and involving specific serum response elements within the promoter. Consistent with these data, we showed that Tat transactivation of the Egr-1 promoter was abrogated when astrocytes were cultured in serum-reduced media. Taken together, these results reveal that Tat directly transactivates Egr-1 expression and suggest that Tat interaction with Egr-1 is probably one of the very upstream molecular events that initiate Tat-induced astrocyte dysfunction and subsequent Tat neurotoxicity.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Egr-1 up-regulation in Tat-expressing U373 cells, U87 cells and primary astrocytes
Cells were transiently transfected with pCDNA3 or pcTat.Myc and harvested after 72 h; Cell lysates of (A) U373 and (B) U87 cells were analyzed for Tat and Egr-1 expression, with β-actin included as a loading control. Primary astrocytes were prepared from brain-targeted inducible Tat transgenic mice and cultured in the absence or presence of 5ug/ml doxcycline (Dox) for up to 3 days (C) then analyzed for Tat and Egr-1 expression. Total RNA was isolated and subjected to RT-PCR using Tat-specific primers with GAPDH used as a loading control. As a control, primary astrocytes were also prepared from wild-type C57/BL6 mice, treated with Dox and analyzed for Egr-1 expression (D). Meanwhile, U373 cells were infected with increasing amounts of VSV-G pseudotyped HIV-GFP virus and harvested after 72 h. Cell lysates were analyzed for Egr-1, GFAP, and Tat expression (E), along with p24 and GFP to ensure infection efficiency. β-actin was included as a loading control. Data is representative of at least three independent experiments.
Figure 2
Figure 2. Egr-1 promoter activity and expression of Egr-1 protein increases in the presence of a specific amount of Tat
U373 cells were transiently transfected with Egr-1 promoter-driven luciferase reporter plasmid pEgr-1p-Luc or control plasmid pGL3 along with increasing amounts of pcTat.Myc and harvested 72h post-transfection. Half of the cells were to detect Egr-1 promoter activity (A) with pCMV-βgal used to normalize for variations in transfection efficiency. The remaining transfected cells were separated and used for Triton-soluble (TS) and Triton-insoluble (TIS) fractions and analyzed for Egr-1, GFAP and Tat expression, with β-actin included as a loading control (B).
Figure 3
Figure 3. Analysis of the functional elements of the human Egr-1 promoter in response to Tat expression
The full length human Egr-1 promoter was cloned from the genomic DNA of U87 cells and inserted into pGL3, and then used to create a panel of Egr-1 promoter mutations (A). Cells were transiently transfected each pEgr-1p-luc mutant plasmid and either pcTat.Myc or pcDNA3, then harvested 72h post-transfection. Cell lysates were used to determine luciferase activity (B), with pCMV-βgal included to normalize the transfection efficiency. Data is representative of at least three independent experiments.
Figure 4
Figure 4. Tat-induced Egr-1 up-regulation is modulated by the serum response element during starvation
U373 cells were transfected with either pEgr-1p-700-luc or pEgr-1p-200-luc along with pcTat.Myc or pcDNA3. At 16h post-transfection the media was replaced with DMEM containing reduced concentrations of serum and incubated for additional 48 hr. Cell lysates were then used to determine luciferase activity, with pCMV-βgal included to normalize the transfection efficiency. Data is representative of at least three independent experiments.
Figure 5
Figure 5. The Egr-1 transcriptional network altered by HIV-1 Tat in astrocytes
HIV-1 Tat protein in astrocytes can be derived from direct HIV infection of these cells themselves. It can also be from HIV-infected microglia/macrophages, followed by its uptake by astrocytes. Tat then transactivates Egr-1 expression, which in turn transactivates p300 expression, which in turn transactivates GFAP expression. Activation of GFAP expression or expression of other target genes of Egr-1 and p300 leads to changes in astrocyte proliferation, survival and function and as a result, impairs neuronal integrity and survival.

Similar articles

Cited by

References

    1. Aicher WK, Sakamoto KM, Hack A, Eibel H. Analysis of functional elements in the human Egr-1 gene promoter. Rheumatol Int. 1999;18:207–14. - PubMed
    1. Beck H, Semisch M, Culmsee C, Plesnila N, Hatzopoulos AK. Egr-1 regulates expression of the glial scar component phosphacan in astrocytes after experimental stroke. Am J Pathol. 2008;173:77–92. - PMC - PubMed
    1. Bell JE, Anthony IC, Simmonds P. Impact of HIV on regional & cellular organisation of the brain. Curr HIV Res. 2006;4:249–57. - PubMed
    1. Bonifaci N, Sitia R, Rubartelli A. Nuclear translocation of an exogenous fusion protein containing HIV Tat requires unfolding. Aids. 1995;9:995–1000. - PubMed
    1. Bratanich AC, Liu C, McArthur JC, Fudyk T, Glass JD, Mittoo S, Klassen GA, Power C. Brain-derived HIV-1 tat sequences from AIDS patients with dementia show increased molecular heterogeneity [In Process Citation] J Neurovirol. 1998;4:387–93. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources